- Type of startup : Life Sciences
- Date of entry : 14/10/2022
- Associated laboratory(ies) : INSERM Montpellier
- See the website
Genome editing has the potential to revolutionize the way we cure severe diseases.
Algenscribe is a Biotechnology company developing a genome editing platform to improve human health. Our strategy is to apply a unique toolbox for precise genome editing. Our mission is to translate our technologies into therapeutics.
